Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00889070 · ClinicalTrials.gov registry record
Respiratory Events Among Premature Infants
A clinical trial of Respiratory Syncytial Virus, sponsored by MedImmune.
- Completed
- Registry status
- 50
- Enrollment target
- 5
- Study locations
NCT00889070: Completed study of Respiratory Syncytial Virus, sponsored by MedImmune.
NCT00889070 is a study of Respiratory Syncytial Virus that has completed, run by MedImmune. The registered enrollment target is 50 participants, below the 390-participant average among 7 other Respiratory Syncytial Virus trials with a reported enrollment target (87% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00889070, a study of Respiratory Syncytial Virus, has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
- 5
- Study locations
Study Summary
Assess the burden of disease associated with RSV infection with premature children in an outpatient setting.
Conditions Studied
Study Locations (5)
California
- Children's Primary Care Medical Group, Inc. - San Diego
Florida
- North Florida Pediatrics - Lake City
Massachusetts
- Woburn Pediatric Associates - Woburn
New York
- Suny Upstate Medical University - Syracuse
Ohio
- Senders Pediatrics - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2008-11 |
| Est. Completion | 2009-05 |
What the finished NCT00889070 record still lists
NCT00889070 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 390-participant average among 7 other Respiratory Syncytial Virus trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Respiratory Syncytial Virus appearing as the primary indexed condition, and to 0 interventions.
NCT00889070 lists 5 locations in 5 states (California, Florida, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT00889070 about?
NCT00889070 is a clinical study titled "Respiratory Events Among Premature Infants". Assess the burden of disease associated with RSV infection with premature children in an outpatient setting.
What is the current status of trial NCT00889070?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2008-11. Estimated completion is 2009-05.
What conditions does trial NCT00889070 study?
This clinical trial studies the following conditions: Respiratory Syncytial Virus.
Who is sponsoring clinical trial NCT00889070?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00889070 being conducted?
This trial has 5 study locations across California, Florida, Massachusetts, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Respiratory Syncytial Virus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of mRNA-1345 Following a Primary Dose of a Licensed Protein Subunit Respiratory Syncytial Virus (RSV) Vaccine in Adult Participants ≥60 Years of Age
ACTIVE NOT RECRUITING · Phase 3
-
A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months
ACTIVE NOT RECRUITING · Phase 1
-
A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults
ACTIVE NOT RECRUITING · Phase 3
-
A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus in Pregnant Women and in Infants Born to Vaccinated Mothers
ACTIVE NOT RECRUITING · Phase 2
-
Dose, Safety, Tolerability and Immunogenicity of a Stabilized Prefusion RSV F Subunit Protein Vaccine, VRC-RSVRGP084-00-VP (DS-Cav1), Alone or With Alum Adjuvant, in Healthy Adults
COMPLETED · Phase 1
-
A Study of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Children 2 to <18 Years of Age at High Risk of Respiratory Syncytial Virus
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia